Danimer Scientific, Inc. (DNMR)
| Previous close | 0.7500 |
| Open | 0.7800 |
| Bid | 0.7467 x 1200 |
| Ask | 0.7585 x 1400 |
| Day's range | 0.6900 - 0.7996 |
| 52-week range | 0.6000 - 3.5600 |
| Volume | |
| Avg. volume | 921,995 |
| Market cap | 83.841M |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5200 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.51 |
- Business Wire
Danimer Scientific Announces Release Date for First Quarter 2024 Results
BAINBRIDGE, Ga., May 01, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024.
Simply Wall St.Industry Analysts Just Upgraded Their Danimer Scientific, Inc. (NYSE:DNMR) Revenue Forecasts By 11%
Shareholders in Danimer Scientific, Inc. ( NYSE:DNMR ) may be thrilled to learn that the analysts have just delivered a...
- Business Wire
Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility
BAINBRIDGE, Ga., April 22, 2024--Danimer Scientific, Inc. (NYSE: DNMR) (the "Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on April 19, 2024, it entered into an asset-based revolving credit and security agreement with Mountain Ridge Capital secured primarily by the Company’s accounts receivable and inventory.
